Biogen Inc.
BIIB
$210.73
-$1.77-0.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 10.42% | 8.70% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 10.42% | 8.70% | |||
| Cost of Revenue | 0.23% | 37.62% | |||
| Gross Profit | 13.75% | 1.72% | |||
| SG&A Expenses | 16.86% | -11.37% | |||
| Depreciation & Amortization | 23.22% | 3.25% | |||
| Other Operating Expenses | -7.28% | 6.15% | |||
| Total Operating Expenses | 7.33% | 5.68% | |||
| Operating Income | 20.83% | 20.31% | |||
| Income Before Tax | -64.95% | 774.46% | |||
| Income Tax Expenses | -40.03% | 919.72% | |||
| Earnings from Continuing Operations | -69.48% | 753.37% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -69.48% | 753.37% | |||
| EBIT | 20.83% | 20.31% | |||
| EBITDA | 19.42% | 14.89% | |||
| EPS Basic | -69.59% | 751.22% | |||
| Normalized Basic EPS | 17.52% | 18.19% | |||
| EPS Diluted | -69.30% | 745.06% | |||
| Normalized Diluted EPS | 17.68% | 17.23% | |||
| Average Basic Shares Outstanding | 0.34% | 0.34% | |||
| Average Diluted Shares Outstanding | 0.20% | 1.16% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||